Akeso Biopharma, is pleased to announce that Dr. Michelle Xia , the company's founder, chairwoman, president, and CEO, will ...

With the support of the RiDYMO® platform, we are able to comprehensively explore various potential targets in drug development, including protein-protein interactions, kinases, GPCRs, ion channels, ...

In the study, 34 patients with stage 4 metastatic pancreatic cancer were randomized to receive ... and appear to be able to ...

A rise in the disease in younger people was not followed by an increase in deaths, a study found, and might be a sign of ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

A local man’s battle with pancreatic cancer has inspired his family and ... her husband underwent a groundbreaking new ...

Medical researchers at the University of Iowa report promising progress in fighting one of the worst cancer killers. The ...

Newsweek spoke with three doctors about the rising rates of colorectal cancer in young people and the lifestyle changes that ...

Q3 2024 Earnings Call Transcript November 15, 2024 Operator: Hello, and welcome to the AIM ImmunoTech Third Quarter 2024 ...

Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...